{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"clinical-endpoint-adjudication","urls":{"read":"https://miscsubjects.com/api/articles/clinical-endpoint-adjudication/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/clinical-endpoint-adjudication/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/clinical-endpoint-adjudication/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/clinical-endpoint-adjudication/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/clinical-endpoint-adjudication/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/clinical-endpoint-adjudication/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/clinical-endpoint-adjudication/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"clinical-endpoint-adjudication","title":"Clinical endpoint adjudication: the committee process, mechanized — with the reviewers' reasoning preserved","register":"technical","tags":["clinical-trials","endpoint-adjudication","adjudication","use-case"],"updated_at":"2026-07-30T14:37:07.888Z","body_excerpt":"## The committee every pivotal trial pays for\n\nWhen a cardiovascular outcomes trial reports that a drug reduced major adverse cardiac events, someone decided, patient by patient, that each chest-pain admission was or was not a myocardial infarction *as the protocol defines one*. That someone is a **clinical endpoint committee** — an endpoint adjudication committee — and it exists because site investigators disagree with each other, with themselves, and with the protocol about what counts as an event.\n\nThe regulatory scaffolding is explicit. ICH E9, the statistical-principles guideline that governs confirmatory trials, recommends that endpoints requiring subjective judgement be assessed by an external evaluation committee blinded to treatment assignment. FDA's 2006 guidance on data monitoring committees is careful to distinguish endpoint adjudication committees as a separate body with a different job: not watching accumulating safety data, but classifying individual events against prespecified definitions. And ICH E9(R1), the estimands addendum, raised the stakes on that classification — whether an event *counts* now feeds directly into which estimand the trial actually estimated. Adjudication is no longer housekeeping; it is part of the definition of the answer.\n\nThe process itself is charter-governed and looks the same across sponsors and CROs. A **charter** prespecifies the event definitions — the clauses of a myocardial infarction, a stroke, a hospitalization for heart failure — and the workflow: reviewers independent of the sponsor and the sites, blinded to treatment arm, working from a **case dossier** (discharge summaries, ECGs, lab values, imaging reports) assembled and de-identified by the trial team. The standard shape is independent dual review: two adjudicators classify the event separately; if they agree, the classification stands; if they disagree, the case escalates to a third reviewer or to full-committee discussion.\n\nThree things about this process are expensive, and one thing about it is strange.\n\nExpensive: the dossier. Chasing source documents from sites, translating, de-identifying, and assembling them is the long pole — cases routinely wait on one missing discharge summary. Expensive: the reviewers. Adjudicators are practicing specialists reviewing cases in batches around clinical schedules, so throughput is measured in weeks per meeting cycle. Expensive: the disagreement. Discordance between reviewers is common enough that every charter has a tie-break procedure, and every discordant case costs a third review or a committee slot.\n\nStrange: **the reasoning disappears.** Two specialists each spend twenty minutes deriving a classification from the charter's definition, clause by clause — did the biomarker rise, was there ischemic evidence, does the timing satisfy the window — and what survives is a checkbox and, at most, a sentence of rationale. When they disagree, the committee reconstructs both derivations from scratch, verbally, in the meeting. The most information-dense artifact the process produces is destroyed at the moment it is produced.\n\n## The process, mechanized\n\nEverything in the preceding paragraph has a mechanical counterpart, and each one is running on this site with public receipts.\n\nThe **charter's event definitions** are the rule set, pinned to a content hash — the version applied to a case is beyond dispute, and a charter amendment is a new hash, so no case can quietly be judged under the wrong version. The **case dossier** is the record, hashed the same way. Several independent model seats — in the running exhibits, **three seats across two model families** — each receive the identical rule set and dossier under a governing constitution that compels a fixed output shape: the verdict; the clauses relied on; a clause-by-clause derivation (did this clause's condition trigger, does that support or defeat the classification, on which evidence records); the records that were *absent*; the stron","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"ICH E9 recommends that endpoints requiring subjective judgement be assessed by an external evaluation committee blinded to treatment assignment, and FDA's 2006 guidance on data monitoring committees distinguishes endpoint adjudication committees as a separate body whose role is to classify events against protocol definitions.","tier":"system","section":"The committee","interaction_risk":false,"status":"active","source_ids":[],"why_material":"The regulatory basis for the process this page mechanizes; the guidance asks for independence, blinding, and prespecified definitions — not for any particular medium of review.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false},{"id":"c2","text":"A clinical endpoint committee operates from a charter that prespecifies event definitions and a disagreement-resolution procedure, typically independent dual review with escalation to a third reviewer or full-committee discussion, and the reviewers' reasoning is recorded only as a final classification with, at most, a brief rationale.","tier":"system","section":"The committee","interaction_risk":false,"status":"active","source_ids":[],"why_material":"The process is already rule-governed and multi-reviewer; what it lacks is a preserved, comparable record of each reviewer's derivation — which is exactly the artifact produced below.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false},{"id":"c3","text":"A governed panel runs the adjudication shape mechanically: the charter's event definitions pinned to a content hash, the case dossier hashed, independent model seats each producing a clause-by-clause derivation in machine-comparable form, and a deterministic gate comparing the derivations.","tier":"system","section":"The process, mechanized","interaction_risk":false,"status":"active","source_ids":["s1","s8"],"why_material":"Every element of the charter-governed committee process has a mechanical counterpart, and each one is running with public receipts.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false},{"id":"c4","text":"The gate authorises only when independent seats agree derivation-for-derivation — same clauses, same trigger states, same evidence records; the one genuine APPROVE on record shows exactly that.","tier":"system","section":"The process, mechanized","interaction_risk":false,"status":"active","source_ids":["s1","s3"],"why_material":"Agreement at the level of reasoning, not just classification, is a stricter concordance standard than a committee vote records.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false},{"id":"c5","text":"A unanimous verdict is refused when the underlying derivations diverge, and the refusal is a permanent record — the disagreement arrives at the human committee pre-structured, with each seat's full derivation preserved.","tier":"system","section":"Disagreement, preserved","interaction_risk":false,"status":"active","source_ids":["s2"],"why_material":"In committee adjudication, discordance is the expensive event; here it is the primary output, formatted for the humans who must resolve it.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false},{"id":"c6","text":"A panel whose dossier is missing a required record seals an abstention that names the absence, rather than classifying on incomplete evidence.","tier":"system","section":"The incomplete dossier","interaction_risk":false,"status":"active","source_ids":["s4"],"why_material":"Incomplete source documents are a dominant driver of adjudication delay and rework; a machine layer that refuses and itemises the gap turns chart-chasing into a targeted query.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false},{"id":"c7","text":"In a calibration study of 30 oracle-labelled synthetic cases through the production gate, seat accuracy was 30/30 (glm-5.2) and 29/30 (kimi-k2.7) and the gate recorded zero wrongful authorisations across 30 sealed panels.","tier":"system","section":"Measured rates","interaction_risk":false,"status":"active","source_ids":["s5"],"why_material":"A sponsor evaluating a triage layer needs a measured wrongful-authorisation rate before anything else, stated with its limits.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false},{"id":"c8","text":"The same machinery audits the charter itself: a governed critique of a case file found eight defects, the lead one a necessity-stated-as-sufficiency error in the rule set that had caused every prior derivation divergence.","tier":"system","section":"The charter audits itself","interaction_risk":false,"status":"active","source_ids":["s6"],"why_material":"Ambiguous event definitions are a known driver of adjudicator discordance; an instrument that finds the ambiguity before first patient in is worth more than one that just processes cases.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false},{"id":"c9","text":"In 72 controlled calls, auditable structure — declared-absent records, flip conditions, rejected alternatives — appeared in zero of 48 ungoverned calls and only under the governing constitution; a three-seat sealed decision costs about half a cent.","tier":"system","section":"The governing text is measured","interaction_risk":false,"status":"active","source_ids":["s7"],"why_material":"The compelled output shape is a measured causal effect of the governing text, not a style, and the cost removes the economic objection to running every case through it.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false},{"id":"c10","text":"This layer is not validated on clinical data: no CEC charter has been run through it, the calibration evidence is 30 synthetic determinate fixtures in one task class, and it is a triage and pre-structuring layer for the human committee — adverse-event and mortality endpoints stay with human adjudicators, and nothing here decides safety.","tier":"system","section":"What this is not","interaction_risk":false,"status":"active","source_ids":[],"why_material":"A sponsor must not be sold more than the evidence supports, and these are the exact boundaries.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false}],"sources":[{"id":"s1","type":"live_surface","url":"https://miscsubjects.com/a/auditable-reasoning-hardened","title":"The derivation-agreement gate — divergence as a recorded refusal","summary":"Independent model seats under a pinned rule set; the gate refuses to authorise when their clause-by-clause derivations diverge, even on a unanimous verdict. Includes the false-convergence defect and its fix.","claim_ids":["c3","c4"],"hash":"d150f9b0a173dd0c10dc41a01a437da55cab615b83f819d3f5ff7c9b0f68490a"},{"id":"s2","type":"live_surface","url":"https://miscsubjects.com/receipt/inv_o6s0exhodd","title":"A unanimous verdict, refused on divergent derivation","summary":"Three seats returned the same conclusion citing the same clauses; two derived it differently, so the gate escalated instead of concluding.","claim_ids":["c5"],"hash":"985245db965db8d70d1b96cbea80dd50b50f85d574d9160878b127b1ea1df7e6"},{"id":"s3","type":"live_surface","url":"https://miscsubjects.com/receipt/inv_wl0rnh136b","title":"The genuine APPROVE — unanimous verdict, identical derivation","summary":"The one clean authorisation on record: every seat fired the same clauses in the same trigger states on the same evidence.","claim_ids":["c4"],"hash":"68bdd78bbae1df6502629050bde3333c864cfdc2b58ef7de85b95353511532dc"},{"id":"s4","type":"live_surface","url":"https://miscsubjects.com/receipt/inv_7rqy8ywuls","title":"Abstention as a sealed outcome — the clean NO_ACTION","summary":"A record was deliberately withheld and the panel declined to conclude, with the absence named in the sealed record — the incomplete-dossier case, executed per decision.","claim_ids":["c6"],"hash":"9311da128178031d72f56a9ff281f07cbab7a0435984a2d1f804f1432a1b1f04"},{"id":"s5","type":"live_surface","url":"https://miscsubjects.com/a/adjudication-calibration-study","title":"The calibration study: 30 oracle-labelled cases through the production gate","summary":"Three seats across two model families on 30 sealed panels: glm-5.2 30/30, kimi-k2.7 29/30, zero wrongful authorisations. Synthetic determinate fixtures only.","claim_ids":["c7"],"hash":"dfc14977f44aee028f030b96b0bf4d28f2e94b442973bb65369adcdbcfae0884"},{"id":"s6","type":"live_surface","url":"https://miscsubjects.com/receipt/inv_qh3ge2x74b","title":"The instrument critiquing its own input: eight defects found","summary":"A governed seat asked to review the case file found eight defects, the lead one a necessity-stated-as-sufficiency error in the rule set that had caused every prior derivation divergence.","claim_ids":["c8"],"hash":"153f99d8a70b29f8ab6481bcfd8ac590a099bedad92cfdb95ee0b8590004ba8e"},{"id":"s7","type":"live_surface","url":"https://miscsubjects.com/a/auditable-reasoning-audited","title":"The 72-call variance study: what the governing text measurably changes","summary":"Three prompt arms x three models x eight runs. Auditable structure appeared in zero of 48 ungoverned calls and only under the constitution; clause-citation agreement rose 0.74 to 0.95; a sealed decision costs about half a cent.","claim_ids":["c9"],"hash":"ce5658b919f82b5da91e0a0f5a07f35bbdb637dc4d1c1b5f1d5704b9584d1364"},{"id":"s8","type":"live_surface","url":"https://miscsubjects.com/a/adjudication-medical-prior-auth","title":"Two weeks against a six-week criterion — the worked medical shape","summary":"A coverage record adjudicated under the constitution: a written criterion, a clinical record, each seat naming the record that would flip its conclusion. The closest published shape to an endpoint dossier.","claim_ids":["c3"],"hash":"2b7d3657f161b1ff8b524c53a335b7da73343a85a7a177729b270fb8f4e9dee9"},{"id":"em_es_f60054cd2d1b46f1ae9c","type":"email","url":"https://miscsubjects.com/letter-ethical-gmbh-2026-07-30","title":"Letter to Mimmo Garibbo — 2026-07-30","claim_ids":[],"hash":"26bdff85fd2344d579d0365e1454f6c5b6c898057c419bd20b8d9b111d900461"}],"anecdotal_sources":[],"scientific_sources":[],"user_reports":[],"related_articles":[],"question_graph":{"slug":"clinical-endpoint-adjudication","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":10,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":10,"claims_total":10,"sources":9,"anecdotal":0,"scientific":0,"user_reports":0,"questions":0,"evidence_ingests":0}}